Press Release: Indi Molecular : GE Healthcare and Indi Molecular to collaborate on diagnostic tool for clinical management of immunotherapy patients

GE Healthcare and Indi Molecular, Inc, a� California-based biotechnology company, have announced plans to develop immune cell-targeted Positron-Emission Tomography (PET) tracer candidates, based on Indi Molecular's proprietary Protein Catalyzed Capture (PCC) technology. These tracer candidates, if successful, could help identify molecular markers of cytotoxic T-cells, and potentially help in the selection and monitoring of immunotherapy patients. Today, despite there being over 2,400 immu...Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=240712